1Njeh CF. Tumor delineation: the weakest link in the search for accuracy in radiotherapy [J]. J Med Phys,2008, 33 (4):136-140.
2Yu JM, Zhong X J, Zhang B J, et al. Pathological validation of gross tumor volume defined by FDG PET/CT and anatomic imaging for esophageal cancer [J]. Intern J Rad Oncol Biol Phys, 2007, 69(3) : 268-270.
3Ilona, Schmalfuss, Anthony A, et al. Postcricoid region and cervical esophagus: normal appearance at CT and MR imaging[J].Radiology,2000,214(1):237-246.
4Simone C B, Ly D, Dan T D, et al. Comparison of intensity-mod- ulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer[ J]. Radiother Oneol, 2011, 101 (3) :376 - 82.
5Mizowaki T, Nishimura Y, Shimada Y, et al. Optimal size oriteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging [ J ]. Int J Radiat Oncol Biol Phys, 1996, 36(5) :1091 -8.
6Hashimoto T, Shirato H, Kato M, et al. Real time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk(OAR) in radiotherapy for thoracic and abdominal tumors[ J]. Int J Radiat Oncol Biol Phys, 2005, 61 (5) :1559 -64.
7Zhao K L, Liao Z X, Buccia M K, et al. Evaluation of respiratory induced target motion for esophageal tumors at the gastroesophageal junction [ J]. Radiother Oncol, 2007, 84 ( 1 ) :283 - 9.
8Maria A. Cone beam computed tomography derived adaptive radio- therapy for radical treatment of esophageal cancer[ J]. Int J Radiat Oncol Biol Phys ,2010,77 ( 2 ) :378 - 83.
